134 related articles for article (PubMed ID: 14457226)
1. [Clinical and experimental data on the neurohumoral vascular and tissue effects of nialamide in cardiovascular and metabolic diseases].
KNICK B
Chemotherapia (Basel); 1962; 4():297-303. PubMed ID: 14457226
[No Abstract] [Full Text] [Related]
2. [On the circulatory action of Niamid in atopic diseases].
STORCK H; HEIM E; KONZELMANN M
Chemotherapia (Basel); 1962; 4():196-202. PubMed ID: 13917507
[No Abstract] [Full Text] [Related]
3. [CLINICAL-CHEMICAL STUDIES ON THE REACTION OF SEROTONIN METABOLISM TO MONOAMINE OXIDASE INHIBITION].
SCHMID E; STOERMER ID; HAAS H; TAUTZ NA; SCHOEN H
Arzneimittelforschung; 1964 Aug; 14():849-52. PubMed ID: 14344123
[No Abstract] [Full Text] [Related]
4. [The therapeutic effect of monoamine oxidase inhibitors in cardiovascular diseases].
FIEGEL G
Chemotherapia (Basel); 1962; 4():141-6. PubMed ID: 13892746
[No Abstract] [Full Text] [Related]
5. [Effectiveness and mode of action of nialamide in peripheral, arterial circulatory disorders].
HUPKA K; THALER H
Chemotherapia (Basel); 1962; 4():102-11. PubMed ID: 14450094
[No Abstract] [Full Text] [Related]
6. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
Savage DD; Mendels J; Frazer A
J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
[TBL] [Abstract][Full Text] [Related]
7. [Cardiac catecholamines after ligation of the coronary artery. Influence of a monoaminoxidase inhibitor (nialamide) on the infarct].
SERRANO PA; VILLANUEVA SA; LERDO DE TEJADAHAY A; CASTANEDA Y; CHAVEZ LARA B; BISTENI A
Arch Inst Cardiol Mex; 1961; 31():197-204. PubMed ID: 13910885
[No Abstract] [Full Text] [Related]
8. [Clinical-experimental studies on the indications and action of 1-(2-benzylcarbamylethyl)-2-isonicotinoyhydrazine (Nialamide)].
KNICK B
Arzneimittelforschung; 1961 Sep; 11():843-7. PubMed ID: 14457227
[No Abstract] [Full Text] [Related]
9. [ON METHODS OF PRODUCTION OF EXPERIMENTAL THROMBOSIS IN RABBIT EARS AND THE SIGNIFANCE OF 5-HYDROXYTRYPTAMINE IN THEIR FORMATION].
BAUMGARTNER HR; STUDER A; REBER K
Thromb Diath Haemorrh; 1963 Jul; 18():485-511. PubMed ID: 14072242
[No Abstract] [Full Text] [Related]
10. Antithrombotic effect of monamine oxidase inhibitor (nialamide).
SHIMAMOTO T; ISHIOKA T; FUJITA T
Circ Res; 1962 Apr; 10():647-57. PubMed ID: 13911935
[No Abstract] [Full Text] [Related]
11. THE PLACE OF MONOAMINE OXIDASE INHIBITOR IN OCCLUSIVE PERIPHERAL VASCULAR DISEASE.
CHHETRI MK; GUHA SR
J Indian Med Assoc; 1965 Feb; 44():172-7. PubMed ID: 14272637
[No Abstract] [Full Text] [Related]
12. The effect of nialamide on endogenously and exogenously elevated blood ammonia levels in patients with liver disease.
BEAL RW; BLACKBURN CR
Australas Ann Med; 1962 Feb; 11():19-23. PubMed ID: 13866111
[No Abstract] [Full Text] [Related]
13. EFFECT OF MONOAMINE-OXIDASE INHIBITORS ON THE CONCENTRATIONS OF 5-HYDROXYTRYPTAMINE IN THE HUMAN BRAIN.
MACLEAN R; NICHOLSON WJ; PARE CM; STACEY RS
Lancet; 1965 Jul; 2(7405):205-8. PubMed ID: 14315227
[No Abstract] [Full Text] [Related]
14. [MONOAMINE OXIDASE INHIBITOR-SEROTONIN INTERACTIONS ON THE AGITATION INDUCED BY MORPHINE IN WHITE MICE].
MERCIER J; LACREUSETTE J
C R Seances Soc Biol Fil; 1963 Oct; 157():1036-9. PubMed ID: 14092086
[No Abstract] [Full Text] [Related]
15. The cardiovascular effects of monoamine oxidase inhibitors.
DAVEY MJ; FARMER JB; REINERT H
Verh Dtsch Ges Kreislaufforsch; 1963; 28():304-6. PubMed ID: 14025281
[No Abstract] [Full Text] [Related]
16. [Inhibition by monoamine oxidase inhibitors of substrate induction of liver tryptophan pyrrolase and increase in brain serotonin].
Samsonova ML; Oksenkrug GF
Vopr Med Khim; 1972; 18(2):198-202. PubMed ID: 4679586
[No Abstract] [Full Text] [Related]
17. [Clinico-therapeutic evaluation of a new inhibitor of monoamine oxidase, nialamide].
PRATESI G; MUZZOLINI M
Minerva Med; 1959 Dec; 50():4447-53. PubMed ID: 14434665
[No Abstract] [Full Text] [Related]
18. [Comparative cardiovascular effects of the inhibitors of monoamine oxidase. Pharmacological effects. Action on cardiac dynamics and metabolism].
CAHN J; HEROLD MM
Chemotherapia (Basel); 1962; 4():262-96. PubMed ID: 13875575
[No Abstract] [Full Text] [Related]
19. Drugs, disease and dentists.
Macalister AD
N Z Med J; 1967 Sep; 66(421):615-9. PubMed ID: 5234551
[No Abstract] [Full Text] [Related]
20. [NEW CONCEPTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS].
ATDJIAN M; MACKENZIE AH; SCHERBEL AL
Prensa Med Argent; 1963 Feb; 50():432-6. PubMed ID: 14064380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
